McKesson Stock Forecast, Price & News

+0.51 (+0.26 %)
(As of 04/19/2021 12:00 AM ET)
Today's Range
Now: $193.69
50-Day Range
MA: $186.24
52-Week Range
Now: $193.69
Volume645,527 shs
Average Volume1.01 million shs
Market Capitalization$30.83 billion
P/E Ratio14.74
Dividend Yield0.87%
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
McKesson logo

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
Year Founded1833



Sales & Book Value

Annual Sales$231.05 billion
Cash Flow$22.55 per share
Book Value$30.01 per share


Net Income$900 million


Market Cap$30.83 billion
Next Earnings Date5/6/2021 (Confirmed)


McKesson: An Undervalued Gem, In A Frothy Market
April 4, 2021 |  seekingalpha.com
Form 8-K MCKESSON CORP For: Mar 31 - StreetInsider.com
April 2, 2021 |  streetinsider.com
McKesson (NYSE:MCK) Trading Down 2.2%
April 1, 2021 |  americanbankingnews.com
See More Headlines


Overall MarketRank

2.15 out of 5 stars

Medical Sector

27th out of 2,024 stocks

Drugs, Proprietaries, & Sundries Industry

3rd out of 14 stocks

Analyst Opinion: 2.5Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
+0.51 (+0.26 %)
(As of 04/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

McKesson (NYSE:MCK) Frequently Asked Questions

Is McKesson a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson
or view top-rated stocks.

What stocks does MarketBeat like better than McKesson?

Wall Street analysts have given McKesson a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but McKesson wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting McKesson?

McKesson saw a increase in short interest in March. As of March 15th, there was short interest totaling 2,580,000 shares, an increase of 50.0% from the February 28th total of 1,720,000 shares. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is presently 2.5 days. Currently, 1.6% of the company's shares are short sold.
View McKesson's Short Interest

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for McKesson

How can I listen to McKesson's earnings call?

McKesson will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings data on Monday, February, 1st. The company reported $4.60 EPS for the quarter, beating the consensus estimate of $4.13 by $0.47. The business had revenue of $62.60 billion for the quarter, compared to analysts' expectations of $61.70 billion. McKesson had a trailing twelve-month return on equity of 45.52% and a net margin of 0.95%. The company's revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company posted $3.81 earnings per share.
View McKesson's earnings history

How has McKesson's stock price been impacted by Coronavirus (COVID-19)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MCK stock has increased by 43.3% and is now trading at $193.69.
View which stocks have been most impacted by COVID-19

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, January 28th. Stockholders of record on Tuesday, March 2nd will be paid a dividend of $0.42 per share on Thursday, April 1st. This represents a $1.68 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend is Monday, March 1st.
View McKesson's dividend history

Is McKesson a good dividend stock?

McKesson pays an annual dividend of $1.68 per share and currently has a dividend yield of 0.87%. McKesson has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of McKesson is 11.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 9.63% next year. This indicates that McKesson will be able to sustain or increase its dividend.
View McKesson's dividend history.

How will McKesson's stock buyback program work?

McKesson announced that its board has initiated a share repurchase program on Tuesday, February 2nd 2021, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's leadership believes its stock is undervalued.

What guidance has McKesson issued on next quarter's earnings?

McKesson updated its FY21 earnings guidance on Tuesday, February, 2nd. The company provided earnings per share guidance of $16.95-17.25 for the period, compared to the Thomson Reuters consensus estimate of $16.43.

What price target have analysts set for MCK?

13 brokers have issued 1 year price objectives for McKesson's stock. Their forecasts range from $165.00 to $231.00. On average, they anticipate McKesson's share price to reach $196.00 in the next twelve months. This suggests a possible upside of 1.2% from the stock's current price.
View analysts' price targets for McKesson
or view top-rated stocks among Wall Street analysts.

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. Brian S. Tyler, CEO & Director (Age 54, Pay $5.56M) (LinkedIn Profile)
  • Mr. Britt J. Vitalone, Exec. VP & CFO (Age 52, Pay $2.3M) (LinkedIn Profile)
  • Ms. Lori A. Schechter, Exec. VP, Chief Legal Officer & Gen. Counsel (Age 59, Pay $2.71M) (LinkedIn Profile)
  • Ms. Tracy L. Faber, Exec. VP & Chief HR Officer (Age 51, Pay $1.26M) (LinkedIn Profile)
  • Mr. Sundeep G. Reddy, Sr. VP, Principal Accounting Officer & Corp. Controller (Age 47)
  • Ms. Nancy Flores, Exec. VP, Chief Information Officer & CTO (Age 54)
  • Ms. Holly Weiss, Sr. VP of Investor Relations
  • Mr. Pete Slone, Sr. VP of Corp. Public Affairs
  • Mr. Kirk Kaminsky, Pres of The US Pharmaceutical & Specialty Solutions Bus.
  • Paul A. Smith, Sr. VP of Taxes

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and The Home Depot (HD).

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Scharf Investments LLC (0.52%), Signature Estate & Investment Advisors LLC (0.12%), Wedge Capital Management L L P NC (0.10%), QV Investors Inc. (0.05%), Royal London Asset Management Ltd. (0.04%) and Retirement Systems of Alabama (0.04%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Sundeep G Reddy and Tracy Faber.
View institutional ownership trends for McKesson

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Scharf Investments LLC, Retirement Systems of Alabama, CX Institutional, Crossmark Global Holdings Inc., Pensionfund Sabic, DnB Asset Management AS, Contravisory Investment Management Inc., and Legacy Private Trust Co.. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, Sundeep G Reddy, and Tracy Faber.
View insider buying and selling activity for McKesson
or view top insider-selling stocks.

Which institutional investors are buying McKesson stock?

MCK stock was purchased by a variety of institutional investors in the last quarter, including QV Investors Inc., Everence Capital Management Inc., Signature Estate & Investment Advisors LLC, Pacer Advisors Inc., Campbell Capital Management Inc., International Assets Investment Management LLC, Centric Wealth Management, and Pensionfund DSM Netherlands.
View insider buying and selling activity for McKesson
or or view top insider-buying stocks.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $193.69.

How much money does McKesson make?

McKesson has a market capitalization of $30.83 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis.

How many employees does McKesson have?

McKesson employs 80,000 workers across the globe.

Does McKesson have any subsidiaries?

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, ClarusONE Sourcing Services LLP, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Echo, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, MED3000, McKesson Europe AG, McKesson International Bermuda IP5A Limited, McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLC, McKesson Sourcing Services Inc., McKesson Specialty Care Distribution LLC, McKesson Strategic Services Limited, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Northstar Healthcare Holdings Unlimited Company, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

When was McKesson founded?

McKesson was founded in 1833.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

Where are McKesson's headquarters?

McKesson is headquartered at 6555 STATE HWY 161, IRVING TX, 75039.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.